Alnylam Pharmaceuticals Inc (ALNY)

Alnylam Pharmaceuticals Inc (ALNY) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $30B; returns 1 day -1.4%, 1 week -3.4%, 1 year -51.7%.

Alnylam Pharmaceuticals is a commercial-stage biopharmaceutical company that pioneers RNA interference (RNAi) therapeutics, a novel class of medicines that silence disease-causing genes. The company's business model is centered on the development and commercialization of treatments for rare and prevalent diseases.

Groups ALNY belongs to

• Biopharmaceutical
• Biotechnology
• Pharmaceuticals
• Commercial Stage
• Commercial Stage Biotech
• Rare Diseases
• Cardiovascular Therapies
• Royalty Streams
• Life Sciences
• Healthcare

ALNY financial model: income statement, cash flow and balance sheet